Municipal health service GGD Amsterdam is taking part in an international scientific study in which a new HIV prevention pill will be tested on humans. The aim is to find out whether experimental drug F/TAF is safe and effective in preventing HIV infection in healthy adults. Gay men and transgender women who have sex with men who are interested in participating in this study, can register with GGD Amsterdam until March 26th, AT5 reports.
The new HIV inhibitor Prep is in high demand among gay men living in the capital. GGD Amsterdam recently announced a trial on the pill that reduces the risk of HIV infection. Only 370 men can participate in the study, but the number of applications were much higher.
GGD Amsterdam has launched a medical study on Prep - a pill that can prevent infection with HIV - among gay men and transgenders. Those interested in joining the study can apply on the GGD Amsterdam website, Soa Aids Nederland reports.